We have recently shown that conditions known to activate AMP-activated protein kinase (AMPK) in primary β-cells can trigger their apoptosis. The present study demonstrates that this is also the case in the MIN6 β-cell line, which was used to investigate the underlying mechanism. Sustained activation of AMPK was induced by culture with the adenosine analogue AICA-riboside or at low glucose concentrations. Both conditions induced a sequential activation of AMPK, c-Jun-N-terminal kinase (JNK) and caspase-3. The effects of AMPK on JNK activation and apoptosis were demonstrated by adenoviral expression of constitutively active AMPK, a condition which reproduced the earlier-described AMPK-dependent effects on pyruvate kinase and acetyl-coA-carboxylase. The effects of JNK activation on apoptosis were demonstrated by the observations that (i) its inhibition by dicumarol prevented caspase-3 activation and apoptosis, (ii) adenoviral expression of the JNK-interacting scaffold protein JIP-1/IB-1 increased AICA-riboside-induced JNK activation and apoptosis. In primary β-cells, AMPK activation was also found to activate JNK, involving primarily the JNK 2 (p54) isoform. It is concluded that prolonged stimulation of AMPK can induce apoptosis of insulin-producing cells through an activation pathway that involves JNK, and subsequently, caspase-3.
Introduction
The AMP-activated protein kinase (AMPK) is a serine/threonine protein kinase that is composed of a catalytic subunit ( ) and two regulatory subunits ( and ) (Davies et al. 1994 , Hardie et al. 1998 . In various cell types, AMPK has been described as a sensor for the energy state, serving as a metabolic master switch (Hardie & Carling 1997 , Hardie et al. 1998 , Winder & Hardie 1999 . Any increase in the intracellular AMP/ATP ratio activates AMPK (Hardie & Carling 1997 , Hardie et al. 1998 , Winder & Hardie 1999 . AMPK activation can thus occur under environmental stress, such as high fructose concentrations in liver, heat shock, exercise and electrical stimulation in skeletal muscle, and ischaemia in heart (Moore et al. 1991 , Corton et al. 1994 , Winder & Hardie 1999 , Marsin et al. 2000 , Musi et al. 2001 . AMPK can also be activated by an adenosine analogue, 5-aminoimidazole-4-carboxamide (AICA)-riboside, following its phosphorylation to AICA-ribotide (also called ZMP), which is an analogue of AMP (Sabina et al. 1985) . This effect of AICA-riboside has been observed in liver cells, pancreatic -cell lines and, to a certain extent, skeletal muscle (Sullivan et al. 1994 , Corton et al. 1995 , Salt et al. 1998 , Da Silva et al. 2000 .
In certain cell types, the AMP/ATP ratio, and hence AMPK activity, strongly depends on the supply and utilisation of substrates, such as glucose. This was the case in -cell lines that were cultured in low glucose (Salt et al. 1998 , Da Silva et al. 2000 . Their AMPK activation has been considered responsible for an inhibition of insulin release (Salt et al. 1998) and for a transcriptional regulation of glucose-responsive genes (Da Silva et al. 2000) . However, in primary -cells, an activation of AMPK can cause apoptosis (Kefas et al. 2003) , which might explain the earlier reported induction of programmed cell death in rat -cells that had been cultured at low glucose concentrations (Hoorens et al. 1996) . In the present study, we found that this is also the case in mouse insulinoma MIN6 cells which had been cultured at low glucose concentrations or in the presence of AICA-riboside. This observation allowed us to use the cell line to examine further the mechanism through which AMPK can induce apoptosis.
Materials and methods

Cell culture and adenoviral infection
Rat pancreatic -cells were isolated and cultured as previously described (Hoorens et al. 1996) . Mouse pancreatic -cell-derived MIN6 cells (passages 20-30) were cultured in DMEM with 15% fetal bovine serum in 0·6 or 25 mM glucose (Van de Casteele et al. 2002) . AICA-riboside and/or dicumarol (Sigma) was added to the incubation medium as indicated. The general caspase inhibitor z-Val-Ala-Asp-fluoromethylketone (z-VAD-fmk) (Bachem, Babendorf, Switzerland) was added to cell cultures at a concentration of 100 µM, 1 h before transferring the cells to apoptogenic culture conditions. MIN6 cells were infected at 100 pfu/cell with an adenovirus (Ad.GFP/ 1 312 ) expressing both a Myctagged constitutively active form of AMPK (protein 1 312 ) and the green fluorescent protein (GFP), or with a control adenovirus (Ad.GFP) expressing only GFP. In other experiments, MIN6 cells were infected at 25 or 50 pfu/cell with an adenovirus (Ad.IB-1) expressing the scaffold protein JIP-1/IB-1 (but not GFP), or with a control adenovirus (Ad.Luc) expressing luciferase. Viral infection was carried out as previously described (Woods et al. 2000) . Ad.IB-1 virus was kindly provided by Dr G Waeber (Department of Internal Medicine, University Hospital, Lausanne, Switzerland).
Detection and quantification of apoptosis
Living, apoptotic and necrotic cells were detected and quantified by fluorescence microscopy using propidium iodide (PI) (Sigma, St Louis, MO, USA) and Hoechst 3342 (Sigma) (Hoorens et al. 1996) . The majority of apoptotic cells that accumulate during culture are microscopically recognised through their fragmented nuclei that fluoresce for both compounds; cells were photographed as described (Hoorens et al. 1996) . Apoptotic cells containing sub-G1 (apoptotic) nuclei were also identified and counted by fluorescence-activated cell sorting (FACS) analysis (Nicoletti et al. 1991 , Van de Casteele et al. 2002 .
Oligonucleosomal DNA fragmentation in MIN6 cells was detected by gel electrophoresis. Following culture, adherent and floating cells were separated, their DNA was extracted by the salting-out procedure (Miller et al. 1988 ) and then precipitated with ethanol, air-dried and dissolved in sterile water. After extraction, DNA was treated with RNAse, and subjected to electrophoresis on 1% agarose gels containing ethidium bromide.
Assay of caspase-3 activity in cell extracts
Cells were lysed in a 10 mM Hepes buffer (pH 7·4) containing 0·1% 3-[(3-cholamidopropyl)-dimethylammonio]-1-propane-sulfonate, 10 mM dithiothreitol, 2 mM EDTA, 1 mM phenylmethanesulphonyl fluoride, 10 µg/ml leupeptin, 10 µg/ml aprotinin and 20 µg/ml pepstatin. Samples (25-50 µg protein) were incubated with 50 µM N-acetyl-Asp-Glu-ValAsp-7-amino-4-methylcoumarin for 3 h at room temperature. The AMC cleavage product was detected fluorimetrically at 460 nm (excitation at 360 nm). Caspase-3 specific activity is expressed as fluorescence units per mg protein and per min. Caspase-3 activity was also expressed relative to the activity measured in untreated cells.
Pyruvate kinase mRNA expression
Polyadenylated RNA was isolated from MIN6 cells and reverse transcribed as previously detailed (Van de Casteele et al. 2002) . PCR was performed on the cDNA using specific primers for L-type pyruvate kinase and -actin (Da Silva et al. 2000) .
Western blotting
Cells were detached by brief incubation at 37 C in PBS containing 1 mM EDTA and 1% BSA.
After two washes, the harvest was lysed by 30-s sonication in RIPA buffer containing protease and phosphatase inhibitors (Heimberg et al. 2000) , and then cleared by centrifugation (12 000 g, 5 min). Protein concentration was measured by the Micro BCA assay (Pierce, Rockford, IL, USA) using BSA as a standard. Under reducing conditions, proteins were resolved by standard 12-15% SDS-PAGE, and transferred to nitrocellulose membranes (Schleicher & Schuell, Dassel, Germany) . Membranes were blocked and incubated in 5% non-fat milk (w/v) in TBS/Tween (10 mM Tris-HCl pH 7·5, 150 mM NaCl, 0·05% (v/v) Tween-20). Monoclonal IgG1 antibodies directed against phospho-(Ser63)-c-Jun (Santa Cruz Biotechnology, Santa Cruz, CA, USA) or C-terminal human c-Myc (clone 9E10·3; Biosource, Camanillo, CA, USA), and polyclonal antibodies against phospho-(Thr183/Tyr185)-c-Jun-N-terminal kinase (JNK) 1/2, total JNK (New England Biolabs, Beverly, MA, USA), phospho-(Ser79)-acetyl-coAcarboxylase (Upstate, Lake Placid, NY, USA), JIP-1/IB-1 (gift of Dr G Waeber, Department of Internal Medicine, University Hospital, Lausanne, Switzerland), GFP (Promega, Madison, WI, USA) or actin (Santa Cruz Biotechnology), were added at 1:400-1:1000 dilution, and the membranes incubated overnight with shaking at 4 C. They were then washed three times for 15 min in TBS/ Tween, and incubated with anti-rabbit IgG horseradish peroxidase (HRP)-linked whole antibody from donkey or with anti-mouse IgG HRP-linked antibody from sheep (Amersham) for 50 min. Proteins were revealed using the enhanced chemiluminescence reaction (Amersham, Piscataway, NJ, USA).
Protein kinase assays
AMPK activity
Cells (5-8 10 6 ) were lysed in 800 µl ice-cold lysis buffer (Marsin et al. 2000) . Total AMPK activity was assayed after precipitation with 10% (w/v) polyethylene glycol 6000. AMPK activity was measured by phosphorylation of the synthetic peptide SAMS (HMRSAMSGLHLVKRR) in the presence of 0·2 mM AMP (Marsin et al. 2000) . One unit of AMPK activity corresponds to 1 pmol of phosphate incorporated per min under the selected assay conditions.
JNK activation
MIN6 cells were lysed in the same buffer as for AMPK activity measurements (Marsin et al. 2000) . Phosphorylation of JNK 1/2 on specific Thr and Tyr residues, and of c-Jun on specific Ser residues was detected by Western blotting.
Statistical analysis of data
Data are expressed as means S.E.M. of at least three independent experiments. Statistical significance of differences with the mean are calculated by Student's two-way t-test for paired data or by ANOVA with the Scheffe F-test for multiple comparisons.
Results
AICA-riboside induced caspase-3 activation and apoptosis in MIN6 cells
Similar to its effects in primary rat -cells, AICAriboside induced apoptosis in subconfluent cultures of the MIN6 -cell line. Apoptotic cells were easily recognised by a fluorescence assay following 24 h culture with AICA-riboside (Fig. 1A) . They detached from the culture dish so that their identity could be confirmed by analysis of the floating material. Thus, this fraction was characterised by oligonucleosomal DNA laddering that did not appear in the presence of the caspase inhibitor zVAD-fmk (Fig. 1B) . Between 0·5 and 2 mM AICA-riboside, FACS analysis indicated a dose-dependent appearance of apoptotic cells, as identified by their sub-G1 DNA content (Fig.  1C) . DNA degradation induced by 2 mM AICAriboside was completely prevented by addition of zVAD-fmk (Fig. 1C) . At 2 mM AICA-riboside, a time-dependent rise in caspase-3 activity was measured between 12 and 36 h of culture (Fig. 1D) . At low glucose (0·6 mM), caspase activity was slightly increased after 12 h, and further raised during the following 36 h up to 8-fold higher values than in control cells cultured at 25 mM glucose (Fig. 1D) .
AICA-riboside-induced AMPK activation and JNK activation followed by caspase-3 activation
When MIN6 cells were cultured with 2 mM AICA-riboside, they rapidly exhibited an elevation in their AMPK activity, starting after 15 min and reaching, after 1 h, a plateau that was maintained for 12 h (Fig. 2A) . The AMPK activation was accompanied by an activation of JNK which became detectable within 1 h and was persistent for up to 24 h (Fig. 2B ). In addition, AMPK activation was also associated with JNK activation in primary -cells (Fig. 2C) . Both activation processes preceded that of caspase-3 ( Fig. 1D ; Kefas et al. 2003) . In primary -cells, increased JNK phosphorylation was noted to occur primarily on the JNK 2 (p54) isoform (Fig. 2C) .
AMPK stimulated JNK in MIN6 cells
To investigate whether AMPK could be responsible for the JNK activation, MIN6 cells were infected with an adenovirus (Ad.GFP/ 1 312 ) that encodes GFP as well as a truncated 1-AMPK catalytic subunit which is c-Myc tagged and which bears a Thr-172-Asp mutation in the activation loop. The mutated 1 312 protein acts as a constitutively active form of AMPK (Woods et al. 2000) . MIN6 cells infected with either Ad.GFP/ 1 312 or Ad.GFP were analysed for the expression of GFP and the mutant protein 1 312 , as well as for AMPK activity, activation of endogenous JNK, and DNA fragmentation. Compared with the Ad.GFP infected cells, the Ad.GFP/ 1 312 -infected cells expressed an elevated AMPK activity (Fig.  3A) . Expression of the constitutively active mutant of AMPK resulted in activation of endogenous JNK (Fig. 3B) , and caused DNA degradation (Fig.  3A) . This indicated that activation of AMPK entails JNK activation and apoptosis in MIN6 cells. Besides these effects, expression of constitutively active AMPK also resulted in a reduced expression of L-type pyruvate kinase mRNA (Fig. 3C) as well as an increased phosphorylation of acetyl-coAcarboxylase in MIN6 cells (Fig. 3D) , showing that expression of the recombinant AMPK reproduced known regulatory effects of AMPK activation (Hardie & Carling 1997 , Hardie et al. 1998 , Da Silva et al. 2000 . 
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JNK activation contributed to caspase-3 activation and apoptosis in MIN6 cells
The respective kinetics of the measured activations (Figs 2 and 1D ) are compatible with a temporal sequence from AMPK, over JNK to caspase-3. We next examined the causality of this sequence in AICA-riboside-induced apoptosis. The JNK inhibitor dicumarol has been demonstrated to inhibit JNK activation in MCF-7 cells without affecting p38 MAPK, I B, or Akt phosphorylation in these cells (Krause et al. 2001) . When added to MIN6 cells, dicumarol was found to inhibit AICAriboside-induced activation of both JNK and caspase-3 (Fig. 4A) . Dicumarol also inhibited DNA degradation induced by AICA-riboside ( Fig. 4A  and B) . These results suggest that JNK activation contributed to caspase-3 activation and apoptosis.
The scaffold protein JIP-1/IB-1 is known to bind to JNK and its upstream kinases forming a transducing complex wherein JNK is activated in response to extracellular stimuli .
We therefore examined the effect of JIP-1/IB1 on AICA-riboside-induced JNK activation and apoptosis. This study was conducted in MIN6 cells that were infected with an adenovirus (Ad.IB-1) expressing JIP-1/IB-1 (Tawadros et al. 2002) . These cells expressed higher levels of the JIP-1/IB-1 protein (Fig. 5A) , and showed increased levels of JNK phosphorylation (Fig. 5A) and apoptosis (Fig.  5B) following AICA-riboside treatment; data were compared with non-infected controls and with cells infected with the luciferase-expressing adenovirus Ad-Luc. These results suggest that IB-1 expression facilitates activation of JNK by AICA-riboside and that this in turn causes increased apoptosis. Taken together, these data indicate that JNK activation mediates AICA-riboside-induced caspase-3 activation and apoptosis in MIN6 cells.
Culture of MIN6 cells at low glucose resulted in a sequence of activations that is comparable with that observed with AICA-riboside
Culture at low glucose (0·6 mM) also induced apoptosis in MIN6 cells as it did in primary -cells ( Fig. 1A ; Kefas et al. 2003) . The kinetics of caspase-3 activation was comparable with that measured during AICA-riboside exposure, starting after 12 h and progressively increasing in the following 36 h up to 8-fold higher values than in control cells cultured at 25 mM glucose (Fig. 1D) .
The caspase-3 activation (Fig. 1D) was preceded by (i) an AMPK activation that started after 30 min, became maximal at 4 h, and persisted for at least 12 h (Fig. 6A) , and (ii) a JNK activation that reached its maximum after 2-4 h (Fig. 6B) . Culture of MIN6 cells at low glucose concentration is thus probably another condition in which apoptosis is induced through the successive activation of AMPK, JNK and caspase-3.
Discussion
Previous studies have shown that rat -cells undergo apoptosis during prolonged exposure to low glucose levels (Hoorens et al. 1996) and to AICA-riboside (Kefas et al. 2003) . It is now shown that this is also the case in insulinoma MIN6 cells. This cell line is known to exhibit an AMPK activation during culture at low glucose (Da Silva et al. 2000) . We therefore used MIN6 cells to identify AMPK-regulated steps that can lead to apoptosis. AMPK was stimulated in two different conditions, namely culture at low glucose concentration, and addition of AICA-riboside.
Culture of MIN6 cells with AICA-riboside resulted in a time-and dose-dependent apoptosis, as documented by fluorescence microscopy and by FACS analysis of nuclear DNA. This effect was mediated by caspase activation as indicated by measurement of caspase-3 activity and by the suppressive action of the general caspase inhibitor zVAD-fmk on oligonucleosomal DNA fragmentation.
Both the exposure to AICA-riboside and culture at low glucose concentration were found to first activate AMPK and JNK, and then caspase-3. When MIN6 cells were infected with adenovirus expressing the constitutively active 1-AMPK catalytic subunit, they underwent activation of endogenous JNK and increased DNA fragmentation, indicating that AMPK activation results in stimulation of JNK and apoptosis. In the presence of dicumarol, a known inhibitor of JNK activation, activation of caspase-3 and cellular DNA fragmentation by AICA-riboside were blunted. In addition, adenovirus expression of the scaffolding protein IB-1/JIP-1 in MIN6 cells augmented their JNK activation in the presence of AICA-riboside and led to an increased apoptosis. AICA-riboside was also found to induce JNK activation in primary -cells. These results thus indicate that activation of AMPK can lead to JNK-mediated caspase-3 activation and apoptosis. JNK activation has previously been shown to contribute to induction of apoptosis in pancreatic -cells under adverse environmental conditions (Ammendrup et al. 2000) . Our study suggests that AMPK is one factor transmitting extracellular signals leading to JNK activation, but it is so far unknown via which mechanism JNK could be activated by AMPK. The results obtained with IB-1-expressing adenovirus suggest that AMPK can stimulate JNK activation at the JNK-interacting scaffold protein JIP-1/IB-1, which is highly expressed in -cells (Abderrahmani et al. 2001) . It is not clear whether IB-1/JIP-1 is also required for AMPK-induced JNK activation and apoptosis; this could be addressed by assessing the effects of IB-1 downregulation. It is also not known which kinases mediate AMPK-induced JNK activation. That IB-1 expression increased the AMPK-induced JNK phosphorylation may indicate the involvement of upstream activators MKK7 and MLK-3, which are known to bind IB-1 and to phosphorylate JNK . Similarly, the mechanisms whereby JNK induces apoptosis in our cell preparations are not known. Downstream apoptosis signalling by JNK in response to AMPK activation may involve phosphorylation of any of the immediate early gene regulating transcription factors Elk1, c-Jun and ATF2 in insulin-producing cells . Phosphorylation of p53, upregulation of p53, transcriptional stimulation of the Bax gene, and upregulation of Fas ligand expression, have been implicated in other systems (Buschmann et al. 2001 , Chen & Lai 2001 , Kobayashi & Tsukamoto 2001 , Mandal et al. 2001 . JNK activation may generate pro-or anti-apoptotic signals depending on the cell type, the stimulus for and the kinetics of the activation. It has been noticed that a pro-apoptotic effect was associated with a sustained rather than with a transient JNK activation (Cross et al. 2000) , a feature that would be compatible with our present observations. This in vitro study suggests that AMPK activation is at least in part responsible for apoptosis of -cells during prolonged exposure to low extracellular glucose levels or to activators of AMPK. While these conditions may not occur in vivo, it is conceivable that they can be mimicked in situations of inadequate intracellular glucose signalling such as glucokinase-deficient type 1 maturity-onset diabetes of the young (MODY). A possible role for AMPK activation in MODY has been suggested in view of its suppressive effect on the transcription factor hepatocyte nuclear factor-4 alpha (Leclerc et al. 2001 ). The present findings also suggest that potentially adverse effects on the viability of -cells should be considered when assessing use of AICA-riboside as treatment for insulin resistance in type 2 diabetes (Winder & Hardie 1999) .
